Visceral leishmaniasis in patients infected with the human immunodeficiency virus

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 12, 1997, Pages 898-903

  Laguna, F ^a   Adrados, M ^a   Alvar, J ^a   Soriano, V ^a   Valencia, M E ^a   Moreno, V ^a   Polo, R ^a   Verdejo, J ^a   Jimenez M I ^a   Martinez P ^b   Martinez M L ^a   Gonzalez Lahoz J M ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIMONY; CD4 ANTIGEN; PENTAMIDINE;

ARTICLE; BLOOD; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; FEVER; HEPATOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MUCOSA; PANCYTOPENIA; PARASITE CULTIVATION; PARASITE ISOLATION; PRIORITY JOURNAL; PROPHYLAXIS; RELAPSE; RETICULOENDOTHELIAL SYSTEM; SPLENOMEGALY; TOXICITY; VISCERAL LEISHMANIASIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALLOPURINOL; AMEBICIDES; AMPHOTERICIN B; ANALYSIS OF VARIANCE; ANTI-HIV AGENTS; ANTIMETABOLITES; ANTIMONY; ANTIPROTOZOAL AGENTS; BLOOD; BONE MARROW; CD4-POSITIVE T-LYMPHOCYTES; CEREBROSPINAL FLUID; DIDANOSINE; DIGESTIVE SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPATIC ENCEPHALOPATHY; HIV; HUMANS; INTESTINAL MUCOSA; KIDNEY FAILURE; LEISHMANIASIS, VISCERAL; LYMPHOCYTE COUNT; MALE; MYOCARDITIS; NEUTROPHILS; PANCREATITIS; PENTAMIDINE; SPAIN; ZIDOVUDINE;

EID: 14444285255     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01700556     Document Type: Article

References (21)

1. Gradoni L, Scalone A, Gramiccia M, Troinai M: Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy. AIDS 1996, 10: 785-791.
2. Montalbán C, Calleja JL, Erice A, Laguna F, Clotet V, Podzamczer D, Cobo J, Mallolas J, Yebra M, Gallego A, the Co-operative Group for the Study of Leishmaniasis in AIDS: Visceral leishmaniasis in patients infected with human immunodeficiency virus. Journal of Infection 1990, 21: 261-270.
3. Altés J, Salas A, Riera M, Udina M, Galmés A, Balanzat J, Ballesteros A, Buades J, Salva F, Villalonga C: Visceral leishmaniasis: another HIV associated opportunistic infection? Report of eight cases and review of the literature. AIDS 1991, 5: 201-207.
4. Medrano FJ, Hernández-Quero J, Jiménez E, Pineda JA, Rivero A, Sánchez-Quijana A, Vélez ID, Viciana P, Castillo R, Reyes MJ, Carvajal F, Leal M, Lissen E: Visceral leishmaniasis in HIV-1 infected individuals: a common opportunistic infection in Spain? AIDS 1992, 6: 1499-1503.
5. Rosenthal E, Marty P, Poizot-Martin I, Reynes J, Pratlong F, Lafeuillade A, Jaubert D, Boulat O, Dereure J, Gambarelli F, Gastaut JA, Dujardin P, Dellamonica P, Cassuto JP: Visceral leishmaniasis and HIV-1 co-infection in southern France. Transactions of the Royal Society of Tropical Medicine and Hygiene 1995, 89: 159-162.
6. Laguna F, López-Vélez R, Soriano V, Montilla P, Alvar J, González-Lahoz JM: Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV. Journal of Infection 1994, 28: 255-259.
7. Laguna F, García-Samaniego J, Soriano V, Valencia E, Redondo C, Alonso MJ, González-Lahoz JM: Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review. Clinical Infectious Diseases 1994, 19: 48-53.
8. Laguna F, Torre Cisneros J, Valencia E, Villanueva J, Moreno V: Efficacy of intermittent liposomal amphotericin B in the treatment of visceral leishmaniasis in patients infected with human immunodeficiency virus. Clinical Infectious Diseases 1995, 21: 711-712.
9. Alvar J, Cañavate C, Gutiérrez-Solar B, Jiménez M, Laguna F, López-Vélez R, Molina R, Moreno J: Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clinical Microbiology Reviews 1997, 10: 298-319.
10. Peters BS, Fish D, Golden R, Evans DA, Bryceson ADM, Pinching AJ: Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Quarterly Journal of Medicine 1990, 77: 1101-1107.
11. Jeannel D, Tuppin P, Brucker G, Danis M, Gentilini M: Imported and autochthonous kala-azar in France. British Journal of Medicine 1991, 303: 336-338.
12. Martínez P, de la Vega E, Laguna F, Soriano V, Puente S, Moreno V, Sentchordi MJ, Garcia Aguado C, González-Lahoz JM: Diagnosis of visceral leishmaniasis in HIV-infected individuals using peripheral blood smears. AIDS 1993, 7: 227-230.
13. López-Vélez R, Laguna F, Alvar J, Pérez Molina JA, Molina R, Martínez P, Villarrubia J: Parasitic culture buffy-coat for diagnosis of visceral leishmaniasis in human immunodeficiency virus-infected patients. Journal of Clinical Microbiology 1995, 33: 937-939.
14. Molina R, Cañavate C, Cercenado E, Laguna F, López Vélez R, Alvar J: Indirect xenodiagnosis of visceral leishmaniasis in 10 HIV-infected patients using colonized Phlebotomus perniciosus. AIDS 1994, 8: 277-279.
15. Herwaldt BL, Berman JD: Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. American Journal of Tropical Medicine and Hygiene 1992, 46: 296-306.
16. Conte JE: Pharmacokinetics of intravenous pentamidine in patients with normal renal function or receiving hemodialysis. Journal of Infectious Diseases 1991, 163: 169-175.
17. Martínez ML, Soriano V, González-Lahoz JM: Prophylaxis of Pneumocystis carinii pneumonia. AIDS 1993, 7: 1133-1134.
18. Ena J, Amador C, Pasquau F, Carbonell C, Benito C, Gutiérrez F, Vilar A: Once-a-month administration of intravenous pentamidine to patients infected with human immunodeficiency virus as prophylaxis for Pneumocystis carinii pneumonia. Clinical Infectious Diseases 1994, 18: 901-904.
19. Matheron S, Cabié A, Parquin F, Mayaud VC, Roux P, Antoine M, Chouguet C, Couland JP: Visceral leishmaniasis and HIV infection: unusual presentation with pleuro-pulmonar involvement, and effect of secondary prophylaxis. AIDS 1992, 6: 238-240.
20. Pérez Molina JA, López-Vélez R, Montilla P, Guerrero A: Pentamidine isothionate as secondary prophylaxis against visceral leishmaniasis in HIV-positive patients. AIDS 1996, 10: 237-238.
21. Ribera E, Ocaña I, de Otero J, Cortes E, Gasser E, Pahissa A: Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients. American Journal of Medicine 1996, 100: 496-501.